Can miRNA Indicate Risk of Illness after Continuous Exposure to M. tuberculosis?

Area of Science:

• Molecular Biology
• Immunology
• Infectious Diseases

Background:

• MicroRNAs (miRNAs) are crucial regulatory elements in biological processes, but their role in infectious diseases like tuberculosis remains unclear.
• Tuberculosis (TB) presents significant challenges in prevention, diagnosis, and treatment, with current therapies causing side effects.
• Identifying novel biomarkers is essential for improving TB management.

Purpose of the Study:

• To identify potential biomarkers for tuberculosis using next-generation sequencing (NGS) techniques.
• To investigate global miRNA expression profiles in tuberculosis patients compared to healthy controls.
• To explore the role of differentially expressed miRNAs in the immune physiopathology of tuberculosis.

Main Methods:

• Collected blood samples from tuberculosis patients (n=9), their healthy physicians (n=6), and external healthy controls (n=7).
• Applied NGS to obtain global miRNA expression profiles.
• Utilized differential expression analysis, target gene prediction, gene set enrichment, and miRNA-gene network analyses.

Main Results:

• Identified 153 differentially expressed miRNAs.
• Found three specific differentially expressed miRNAs (hsa-let-7g-5p, hsa-miR-486-3p, and hsa-miR-4732-5p) between tuberculosis patients and their physicians.
• These miRNAs are implicated in granuloma regulation and immune response.

Conclusions:

• MicroRNAs play a role in immune modulation by regulating gene expression in immune cells.
• The identified miRNAs show potential as biomarkers for tuberculosis diagnosis and understanding disease mechanisms.
• Further research into miRNAs could lead to improved diagnostic tools and therapeutic strategies for tuberculosis.